Back to Trades
Other4
ENANTA PHARMACEUTICALS INC
ENTA
Total Value
$283.4K
Company Information
- Company Name
- ENANTA PHARMACEUTICALS INC
- Ticker Symbol
- ENTA
- CIK
- 0001177648
Insider Information
- Name
- Hata Yujiro S
- Role
- Director
- Location
- WATERTOWN, MA
Director
Filing Details
- Filing Date
- Mar 13, 2026
- Transaction Date
- Mar 11, 2026
- Accession Number
- 0002064832-26-000140
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Derivative | 20,000 | $14.17 | Grant/Award | $283.4K |
Footnotes
- (F1)Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 11, 2026), with the final monthly installment vesting no later than the nearest trading day on the Nasdaq Global Select Market preceding the 2027 annual meeting of stockholders.